fda approval for tirzepatide approves new weight-loss drug Zepbound (tirzepatide) F.D.A. Approves New Obesity Drug

Stopping GLP-1 drugs may lead to weight regain if underlying habits are not addressed

My mother got to see, in person, how this was affecting me

Dextroamphetamine increases activity in the central nervous system by boosting neurotransmitters such as dopamine and norepinephrine, which can improve symptoms of ADHD, like inattention and impulsivity

Modern dieting often looks more like somebody wandering around under fluorescent lighting emotionally negotiating with a rice cake

Gallbladder problems , including gallstones, have also been associated with GLP-1 therapy, likely related to rapid weight loss and changes in bile composition

Mild changes in urinary frequency often dont get coded as adverse events unless theyre disruptive